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Abstract The cerebral deposition of 39-42 residue amyloid ~- 
protein (A[~) is a histopathological characteristic of Alzheimer's 
disease. The present study is aimed at finding proteinases 
responsible for the intracellular clearance of A[~. The A~- 
degrading proteinase was purified from rat brain. Amino- 
terminal sequence analysis indicated the A~-degrading protein- 
ase was cathepsin D. Purified cathepsin D hydrolyzed A[~ 
between Phe 19 and Phe 2°. Cathepsin D is likely to be involved in 
the intracellular clearance of aggregatable A[~, since A[~ 
fragments with Phe 2° at the amino-terminus have been reported 
to be secreted from several ines of cultured cells. 
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1. Introduction 
One of the hallmarks of Alzheimer's disease is the cerebral 
deposition of 3942 residue amyloid ]3-peptide (A[3). A[3 is 
produced by proteolytic processing from ]3-amyloid precursor 
protein ([3APP), a 110-130 kDa type I integral membrane 
glycoprotein. A]3 is secreted from most cells including neurons 
and the overproduction of A[3 is likely to lead to the forma- 
tion of neuritic plaques and vascular deposits in the brain 
microvessels (see [1] for review). Therefore, it is critically im- 
portant to maintain the normal balance between production 
and clearance of A[3 to prevent he cerebral deposition of A[3. 
The proteolytic processing of [3APP has been studied using 
cultured cells and three endoproteinases designated c~-, [3-, and 
y-secretases have been proposed to be engaged in the proces- 
sing. The ct-secretase has been shown to be present at or near 
the cell surface [2] and cleaves [3APP within the A[3 region (at 
Lys16-Leu 17 of A[3) to produce a large secreted derivative 
(APPs) and a 9 kDa membrane-associated fragment, neither 
of which can produce amyloid because they do not contain 
the entire A[3 [3,4]. The ]3-secretase cleaves [3APP at the NH2- 
terminus of AI3, producing a 10 kDa COOH-terminal frag- 
ment, which is further cleaved at the COOH-terminus of A~ 
by 7-secretase. It has been described that A~ formation occurs 
at least in part in the endosomes/lysosomes [5,6] after cell 
surface ]3APP has been reinternalized via clathrin-coated pits 
[7 9]. 
In addition to the cleavage after Lys 16 of A[3 region, other 
cleavages are also suggested to be important o eliminate A]3 
generation. For instance, Busciglio et al. reported that CHO 
cells secreted A]3 fragments with a heterogeneous NH2-ter- 
minal sequence, reflecting cleavages after Lys 16, Phe 19, and 
Va124 [10] and Haass et al. described that kidney 293 cells 
secreted A[~-related peptides, reflecting cleavages after Lys 16, 
Leu a7 and Phe 19 [11]. It is interesting that both cell lines pro- 
duce A]3-related peptides with Phe 2° at the NH2-terminus. 
However, proteinase(s) that cleave after Phe 19 of the A[3 re- 
gion have not been identified. 
The present work was aimed at finding proteinases respon- 
sible for the degradation of A]3 in the brain and it was found 
that cathepsin D (EC 3.4.23.5) was the major proteinase that 
hydrolyzed A~ in the middle of the sequence to eliminate the 
amyloidogenic peptide. The involvement of cathepsin D in the 
elimination of A[3 has been suggested by the observations that 
the proteinase specifically cleaves full-length A[3 between 
Phe 19 and Phe 2°. 
2. Materials and methods 
2.1. Materials 
Synthetic A]31 42 and A[31 2s were purchased from American Pep- 
tide Co. (Sunnyvale, CA, USA). The purity of all synthetic peptides 
was above 98% on RP-HPLC. Pepstatin A, leupeptin, and E-64 were 
purchased from Sigma (St. Louis, MO, USA). Pepstatin A was 
coupled with Affi-Gel 10 (BioRad) by incubating the mixture of 
0.05 mmol of pepstatin A, 0.05 mmol of diisopropylcarbodiimide, 
0.06 mmol of hydroxybenzotriazole, and aminoethyl-Affi-Gel 10 
(packed volume; 2 ml) in 2.5 ml of dimethylformamide at room tem- 
perature for 15 h. After coupling gels were successively washed with 
dimethylformamide, 1 M acetic acid, and 0.5 M borate buffer, pH 9.5. 
2.2. Digestion of A[I by the brain extract 
Rat brain (2 g, stored at -20°C) was minced in 20 ml of Tris- 
buffered saline (TBS; 0.15 M NaCl, 10 mM Tris-HC1, pH 7.5), and 
homogenized for 30 s with a Polytron homogenizer at4°C. The brain 
extract was obtained as the supernatant after the homogenate was 
centrifuged at 105xg for 60 min. To estimate the pH optimum of 
AJ3 hydrolysis, Al3a 28 (1 nmol) was incubated with the rat brain 
extract (5 ~tl) in 20 lal of 0.1 M acetate buffer (pH 3.5 and 4.5) or 
phosphate buffer (pH 5.5-7.5), at 37°C for 30 min. After incubation 
the reaction was stopped by adding 0.1 ml of 0.05% trifluoroacetic 
acid (TFA) followed by heating at 100°C for 5 min. The reaction 
mixture was filtered through a membrane filter (0.22 ~tm; Amicon) 
and then the filtrate was chromatographed on an Inertsil 300C8 col- 
umn (4.6x100 mm; GL Science Inc., Japan). The peptides were 
eluted at a rate of 1 ml/min with a 20-min linear gradient of 0-40% 
acetonitrile in 0.05% TFA and monitored by absorbance at 215 nm. 
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2.3. Purification of A[~-degrading proteinase 
Rat brain (30 g) was homogenized in 300 ml of TBS containing 0.5 
mM phenylmethylsulfonyl fluoride (PMSF), 1 laM leupeptin, and 5 
mM EDTA, and centrifuged at 2 × 104 × g for 30 min. After the super- 
natant fraction was mixed with one-tenth volume of 1 M acetate 
buffer, pH 4.5, precipitates were removed by centrifugation at 
105Xg for 60 min. The supernatant fraction (290 ml) containing 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PII S00 l 4 -5793(96)0  1 087-3 
A 108 units of A[3-degrading proteinase was loaded on a column (1 ml) of pepstatin A-Affi-Gel 10 equilibrated with 0.1 M acetate buffer, pH 
4.5. After the column was washed with 10 ml of the column buffer, 
A~-degrading proteinase was eluted with 0.5 M borate buffer, pH 9.6, 
and 0.5-ml fractions were collected, monitored by absorbance at 280 
nm, and proteinase activity assayed using A[3a 28 as substrate. The 
proteinase preparation purified by affinity chromatography was 
loaded on a column (16x600 mm) of Superdex 75 pg column (Phar- 
macia Biotech) equilibrated with TBS. The column was eluted with 
TBS at a flow rate of 0.5 ml/min and 1-ml fractions were collected, 
monitored by absorbance at 215 nm, and Al3-degrading activity as- 
sayed. The obtained enzyme preparation contained 34.4 units of AI3- 
degrading activity (specific activity: 141 units/mg protein). One unit of 
A[3-degrading activity was defined as the amount of proteinase re- 
quired to hydrolyze 1 gmol of A[31-2s after Phe a9 in 0.1 M acetate 
buffer, pH 4.5, at 37°C in 1 h. SDS-PAGE was performed using 10% 
acrylamide gel with Tris-glycine buffer system [12] and gels were 
stained with Coomassie brilliant blue R-250. 
2.4. Hydrolysis of A[~ by cathepsin D 
A~I 42 (1 nmol) was incubated with 1.2 gg of purified brain cathep- 
sin D in 40 gl of 0.1 M acetate buffer, pH 4.5, at 37°C for 4 h. After 
incubation the reaction mixture was chromatographed on an lnertsil 
300C8 column (4.6 × 100 mm) with a solvent system containing 0.05% 
TFA. The peptides were eluted at a rate of 1 ml/min with a 30-min 
linear gradient of 0 60% acetonitrile containing 0.05% TFA and frac- 
tions with UV absorbance at 215 nm were collected for peptide se- 
quencing. 
2.5. Analysis of protein sequence 
Samples were spotted on polybrene-coated glass fiber disks and 
sequenced on an Applied Biosystems model 491 protein sequencing 
system. Data were analyzed using a model 610A Data Analysis Pro- 
gram. 
3. Results and discussion 
To examine the effects of pH on the degradation of A[3, the 
rat brain extract was incubated with A[3a 28 at 37°C for 30 
min, and subsequently the degradation products were ana- 
lyzed on RP-HPLC (Fig. 1A). Since A]3 was effectively hydro- 
lyzed at pH 3.54.5,  the following experiments were per- 
formed at pH 4.5. To characterize the proteinase(s) that 
hydrolyze A[3, the brain extract was incubated with A131_ 2s 
in the presence of specific proteinase inhibitors and the incu- 
bat ion mixture was analyzed on RP-HPLC (Fig. 1B). Neither 
E-64 (cysteine proteinase inhibitor) nor  leupeptin (serine and 
cysteine proteinase inhibitor) inhibited the hydrolysis of 
A131-2s by the brain extract, whereas pepstatin A (aspartic 
proteinase inhibitor) completely inhibited the proteolysis. 
Neither EDTA (5 mM)  nor  PMSF (1 mM) inhibited the hy- 
drolysis of A[3 (data not shown). The results suggest hat the 
major proteinase involved in the hydrolysis of A~ is aspartic 
proteinase. 
The A[3-degrading aspartic proteinase was purified by affi- 
nity chromatography using pepstatin A as an absorbent im- 
mobil ized on Affi-Gel 10 (see Section 2). After affinity chro- 
matography,  gel f i ltration was performed to remove a ~ 70 
kDa protein which had no Al3-degrading activity (Fig. 2A). 
By these two steps of chromatography the Al3-degrading pro- 
teinase was purified approximately 3000-fold with 32% recov- 
ery. The enzyme preparat ion after gel fi ltration gave a single 
band on SDS-PAGE at ~43 kDa (Fig. 2B). The NH2-ter- 
minal sequence of the purified A~-degrading enzyme was de- 
termined to be EPVSELLKNYLDAQY,  which is consistent 
with the protein sequence deduced from the nucleotide se- 
quence of rat cathepsin D cDNA cloned from a pituitary 
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Fig. 1. Hydrolysis of AI3 in the middle of the sequence with rat 
brain extract. A: Effects of pH on the hydrolysis of A~I 28. A[31_28 
was incubated at 37°C for 30 min with the brain extract. B: Inhibi- 
tion of Al3-degrading proteinase in the brain extract. A[31-z8 was in- 
cubated at 37°C with the brain extract in 0.1 M acetate buffer, pH 
4.5, containing E-64 (3200 laM), leupeptin (1200 ~M), or pepstatin 
A (1.5 gM). After 30-min incubation products were analyzed on 
RP-HPLC. 
tein sequence indicated that the AI3-degrading proteinase was 
cathepsin D. Cataldo et al. demonstrated the presence of ca- 
thepsin D and its mRNA in human brain neurons by immu- 
nohistochemical studies and by in situ hybridization [14], sug- 
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gesting brain neurons produce the same cathepsin D as pe- 
ripheral tissues. 
To show cathepsin D is able to degrade aggregatable full- 
length A~, A~I 42 was incubated with the proteinase purified 
from rat brain. Fig. 3 shows that cathepsin D hydrolyzes 
A131_42 after Phe 19 and Leu 34, producing A~I 19, A[320 34, 
and A1~3~-42. About 80% of AI]I 42 was hydrolyzed in 4 h. 
The specific hydrolysis of A[3 between Phe 19 and Phe 2° by 
cathepsin D suggests that this endoproteinase contributes to 
the generation of A~-related peptides with Phe 2° at the NH2- 
terminus which have recently been described to be secreted 
from several ines of cultured cells [10,11]. 
The present results give direct evidence that cathepsin D is a 
major proteinase in the brain that is able to degrade full- 
length AI3 in the middle of the sequence. Since cathepsin D 
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Fig. 2. Purification of AI3-degrading proteinase. A: Gel filtration of 
affinity-purified AI3-degrading enzyme. The proteinase preparation 
purified by affinity chromatography was loaded on a column 
(16x600 mm) of Superdex 75 pg column equilibrated with TBS. 
The column was eluted with TBS at a flow rate of 0.5 ml/min and 
1 ml fractions were collected, monitored by absorbance at 215 nm, 
and proteinase activity assayed every second fraction. B: SDS- 
PAGE of the purified enzyme. Lane a: 2 gg of the enzyme prepara- 
tion after affinity chromatography; lane b: 2 p_g of the enzyme pre- 
paration after gel filtration; lane c: molecular weight standard. 
e, I  
0.3  -- 
0 .2  - -  
0°1  - -  
0-  
Oh 
4 h t-.l-19 
[ :-.20-34 
J . . .  lil i-1-42 
I I I I I I I 
0 $ 10 15 20 25 30 35 
Retent ion  T ime (rain) 
Fig. 3. Cleavage of full-length A[3 by cathepsin D. A[31 42 (1 nmol) 
was incubated with 1.2 ~tg of purified brain cathepsin D in 40 tal of 
0.1 M acetate buffer, pH 4.5, at 37°C for 4 h. After incubation the 
peptides were separated on an RP-HPLC and peaks with UV ab- 
sorbance at 215 nm were collected for peptide sequencing. 
erated by proteolytic processing [5,6], it is possible that 
cathepsin D eliminates AI3 at the site of generation. It has 
been described that cathepsin D was capable of producing 
the cleavages resulting in A~ generation, especially when a 
synthetic peptide with Swedish-type mutation was used as 
substrate [15]. In conclusion, I would like to propose that 
cathepsin D is able to work as an A~-producing enzyme es- 
pecially for Swedish-type mutants and also as an A~-eliminat- 
ing enzyme by cleaving at PhOg-Phe 2° of the A~ region and 
that the balance between the two cleavages affects the secre- 
tion of the amyloidogenic peptide. 
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